Gene Page: SMTN
Summary ?
GeneID | 6525 |
Symbol | SMTN |
Synonyms | - |
Description | smoothelin |
Reference | MIM:602127|HGNC:HGNC:11126|Ensembl:ENSG00000183963|HPRD:03675|Vega:OTTHUMG00000151203 |
Gene type | protein-coding |
Map location | 22q12.2 |
Pascal p-value | 0.015 |
Sherlock p-value | 0.927 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
GSMA_I | Genome scan meta-analysis | Psr: 0.031 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs3811019 | chr1 | 114471582 | SMTN | 6525 | 0.08 | trans | ||
rs1881393 | chr2 | 197274131 | SMTN | 6525 | 0.02 | trans | ||
rs534654 | chr4 | 56290219 | SMTN | 6525 | 0.2 | trans | ||
rs17139265 | chr5 | 115578809 | SMTN | 6525 | 0.13 | trans | ||
rs2240700 | chr5 | 140773387 | SMTN | 6525 | 0.05 | trans | ||
rs6867460 | chr5 | 140778255 | SMTN | 6525 | 0.06 | trans | ||
rs6905929 | chr6 | 13350245 | SMTN | 6525 | 0.01 | trans | ||
rs318585 | chr7 | 34294644 | SMTN | 6525 | 0.09 | trans | ||
rs6946440 | chr7 | 154494615 | SMTN | 6525 | 0.06 | trans | ||
rs10503735 | chr8 | 23759167 | SMTN | 6525 | 0.09 | trans | ||
rs7832761 | chr8 | 50133484 | SMTN | 6525 | 0 | trans | ||
rs4909799 | chr8 | 135878114 | SMTN | 6525 | 0.19 | trans | ||
rs1930367 | chr9 | 81584844 | SMTN | 6525 | 0.04 | trans | ||
rs10143486 | chr14 | 92848957 | SMTN | 6525 | 0.02 | trans | ||
rs16955618 | chr15 | 29937543 | SMTN | 6525 | 0.02 | trans | ||
rs801995 | chr16 | 6392825 | SMTN | 6525 | 0.17 | trans | ||
rs2980977 | chr18 | 60083075 | SMTN | 6525 | 0.01 | trans | ||
rs17059620 | chr18 | 74293081 | SMTN | 6525 | 0.2 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003779 | actin binding | TAS | 8707825 | |
GO:0008307 | structural constituent of muscle | TAS | 8707825 | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007517 | muscle development | TAS | 8707825 | |
GO:0006939 | smooth muscle contraction | TAS | 8707825 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005737 | cytoplasm | IEA | - | |
GO:0015629 | actin cytoskeleton | TAS | 8707825 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER DN | 169 | 118 | All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE LIVE UP | 485 | 293 | All SZGR 2.0 genes in this pathway |
UDAYAKUMAR MED1 TARGETS DN | 240 | 171 | All SZGR 2.0 genes in this pathway |
WANG ESOPHAGUS CANCER VS NORMAL UP | 121 | 72 | All SZGR 2.0 genes in this pathway |
XU HGF SIGNALING NOT VIA AKT1 6HR | 26 | 15 | All SZGR 2.0 genes in this pathway |
TOMLINS PROSTATE CANCER DN | 40 | 33 | All SZGR 2.0 genes in this pathway |
BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | 637 | 377 | All SZGR 2.0 genes in this pathway |
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN | 382 | 224 | All SZGR 2.0 genes in this pathway |
KOYAMA SEMA3B TARGETS UP | 292 | 168 | All SZGR 2.0 genes in this pathway |
BENPORATH CYCLING GENES | 648 | 385 | All SZGR 2.0 genes in this pathway |
AMIT EGF RESPONSE 480 HELA | 164 | 118 | All SZGR 2.0 genes in this pathway |
AMIT EGF RESPONSE 480 MCF10A | 43 | 26 | All SZGR 2.0 genes in this pathway |
KANNAN TP53 TARGETS UP | 58 | 40 | All SZGR 2.0 genes in this pathway |
SHEPARD CRUSH AND BURN MUTANT DN | 185 | 111 | All SZGR 2.0 genes in this pathway |
REN ALVEOLAR RHABDOMYOSARCOMA DN | 408 | 274 | All SZGR 2.0 genes in this pathway |
KUNINGER IGF1 VS PDGFB TARGETS UP | 82 | 51 | All SZGR 2.0 genes in this pathway |
WANG SMARCE1 TARGETS UP | 280 | 183 | All SZGR 2.0 genes in this pathway |
BILD MYC ONCOGENIC SIGNATURE | 206 | 117 | All SZGR 2.0 genes in this pathway |
BILD HRAS ONCOGENIC SIGNATURE | 261 | 166 | All SZGR 2.0 genes in this pathway |
SARRIO EPITHELIAL MESENCHYMAL TRANSITION UP | 180 | 114 | All SZGR 2.0 genes in this pathway |
WEST ADRENOCORTICAL TUMOR DN | 546 | 362 | All SZGR 2.0 genes in this pathway |
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS | 80 | 56 | All SZGR 2.0 genes in this pathway |
FOURNIER ACINAR DEVELOPMENT LATE 2 | 277 | 172 | All SZGR 2.0 genes in this pathway |
CHANDRAN METASTASIS DN | 306 | 191 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13 | 172 | 107 | All SZGR 2.0 genes in this pathway |
WHITFIELD CELL CYCLE G2 M | 216 | 124 | All SZGR 2.0 genes in this pathway |
PURBEY TARGETS OF CTBP1 NOT SATB1 UP | 344 | 215 | All SZGR 2.0 genes in this pathway |
PEDERSEN METASTASIS BY ERBB2 ISOFORM 7 | 403 | 240 | All SZGR 2.0 genes in this pathway |
KRIEG HYPOXIA NOT VIA KDM3A | 770 | 480 | All SZGR 2.0 genes in this pathway |
ALFANO MYC TARGETS | 239 | 156 | All SZGR 2.0 genes in this pathway |
ACEVEDO FGFR1 TARGETS IN PROSTATE CANCER MODEL DN | 308 | 187 | All SZGR 2.0 genes in this pathway |
LIM MAMMARY STEM CELL UP | 489 | 314 | All SZGR 2.0 genes in this pathway |